Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Washington, DC
NPI: 1649447558Primary Practice Location
WASHINGTON DC VA MEDICAL CENTER
50 Irving St Nw, Washington, DC
Primary Employer
Washington VA Medical Center
va.gov
HQ Phone
Get M.D. Maneesh's Phone Numberphone_androidMobile
Get M.D. Maneesh's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
DC State Medical License
Genetic variants of mucins: unexplored conundrum.
Authors: Surinder Batra
Journal: Carcinogenesis
Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
Authors: Chi Lin, Dwight Jones, Surinder Batra, William Lydiatt
Publication Date: 2017-02
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.
Authors: Vinod Balachandran, Yonathan Ararso, Jacqueline Bromberg, Enrico Danzer, Sujit Sheth, William Jarnagin, Norman Lacayo, Yasmin Khakoo, Emily Slotkin, Paul Meyers, David Kelsen, Todd Heaton, Surinder Batra, Leonard Wexler, Kevin De Braganca, Shakeel Modak, David Lyden, Caitlin Williams, Charles Rudin, Martin Weiser,
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Sunitinib Malate, BIOLOGICAL: Nivolumab, OTHER: Laboratory Biomarker Analysis, DRUG: Osimertinib, PROCEDURE: Biospecimen Collection, DRUG: Dabrafenib, DRUG: Crizotinib, DRUG: Sapanisertib, DRUG: Taselisib, PROCEDURE: Computed Tomography, BIOLOGICAL: Trastuzumab, DRUG: Trametinib, PROCEDURE: Multigated Acquisition Scan, DRUG: Palbociclib, DRUG: Afatinib, DRUG: Ulixertinib, OTHER: Cytology Specimen Collection Procedure, DRUG: Dasatinib, DRUG: Vismodegib, DRUG: Afatinib Dimaleate, DRUG: Adavosertib, PROCEDURE: Biopsy Procedure, DRUG: Defactinib, PROCEDURE: Radionuclide Imaging, BIOLOGICAL: Trastuzumab Emtansine, DRUG: Copanlisib, PROCEDURE: Echocardiography Test, DRUG: PI3K-beta Inhibitor GSK2636771, DRUG: Larotrectinib, BIOLOGICAL: Relatlimab, DRUG: Copanlisib Hydrochloride, DRUG: Capivasertib, DRUG: Erdafitinib, DRUG: Larotrectinib Sulfate, DRUG: Binimetinib, BIOLOGICAL: Pertuzumab, DRUG: Ipatasertib, DRUG: Dabrafenib Mesylate, DRUG: Defactinib Hydrochloride, DRUG: Fexagratinib, PROCEDURE: Radiologic Examination
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI), Canadian Cancer Trials Group
Intervention / Treatment: PROCEDURE: surgery, DRUG: FOLFOX (chemotherapy), OTHER: 5 FUCMT (chemoradiation), PROCEDURE: magnetic resonance imaging or endorectal ultrasound
Publication Date: 2020-01-06